A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy
A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy
Objective
We studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials and to illuminate the progression of pathophysiology.
Methods
Twenty three patients with progressive supranuclear palsy (Richardson’s syndrome) were compared to 22 matched controls at baseline and 16 of these patients compared at baseline and one year using: the progressive supranuclear palsy rating scale; the unified Parkinson’s disease rating scale; the revised Addenbrooke’s cognitive examination; the frontal assessment battery; the cubes section of the visual object and space perception battery; the Hayling and Brixton executive tests; and saccadic latencies.
Results
Patients were significantly impaired in all domains at baseline. However, cognitive performance was maintained over a year on the majority of tests. The unified Parkinson’s disease rating scale, saccadic latency and progressive supranuclear palsy rating scale deteriorated over a year, with the latter showing the largest change. Power estimates indicate that using the progressive supranuclear palsy rating scale as an outcome measure in a clinical trial would require 45 patients per arm, to identify a 50% reduction in rate of decline with 80% power.
Conclusions
Motor, oculomotor and cognitive domains deteriorate at different rates in progressive supranuclear palsy. This may be due to differential degeneration of their respective cortical-subcortical circuits, and has major implications for the selection of outcome measures in clinical trials due to wide variation in sensitivity to annual rates of decline.
1-14
Ghosh, Boyd C.P.
b86fbe01-3d3d-4a55-9d38-ee15ab4da0f2
Carpenter, Roger H.S.
d7b5063c-f90f-4f66-bbf8-a2a62d03eae8
Rowe, James B.
48b81593-e26b-431f-b2c0-e5aa1cf7c68c
10 September 2013
Ghosh, Boyd C.P.
b86fbe01-3d3d-4a55-9d38-ee15ab4da0f2
Carpenter, Roger H.S.
d7b5063c-f90f-4f66-bbf8-a2a62d03eae8
Rowe, James B.
48b81593-e26b-431f-b2c0-e5aa1cf7c68c
Ghosh, Boyd C.P., Carpenter, Roger H.S. and Rowe, James B.
(2013)
A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
PLoS ONE, 8 (9), .
(doi:10.1371/journal.pone.0074486).
(PMID:24058574)
Abstract
Objective
We studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials and to illuminate the progression of pathophysiology.
Methods
Twenty three patients with progressive supranuclear palsy (Richardson’s syndrome) were compared to 22 matched controls at baseline and 16 of these patients compared at baseline and one year using: the progressive supranuclear palsy rating scale; the unified Parkinson’s disease rating scale; the revised Addenbrooke’s cognitive examination; the frontal assessment battery; the cubes section of the visual object and space perception battery; the Hayling and Brixton executive tests; and saccadic latencies.
Results
Patients were significantly impaired in all domains at baseline. However, cognitive performance was maintained over a year on the majority of tests. The unified Parkinson’s disease rating scale, saccadic latency and progressive supranuclear palsy rating scale deteriorated over a year, with the latter showing the largest change. Power estimates indicate that using the progressive supranuclear palsy rating scale as an outcome measure in a clinical trial would require 45 patients per arm, to identify a 50% reduction in rate of decline with 80% power.
Conclusions
Motor, oculomotor and cognitive domains deteriorate at different rates in progressive supranuclear palsy. This may be due to differential degeneration of their respective cortical-subcortical circuits, and has major implications for the selection of outcome measures in clinical trials due to wide variation in sensitivity to annual rates of decline.
Other
fetchObject.action_uri=info_doi%2F10.1371%2Fjournal.pone.0074486&representation=PDF
- Version of Record
Available under License Other.
More information
Published date: 10 September 2013
Organisations:
Medical Education
Identifiers
Local EPrints ID: 366836
URI: http://eprints.soton.ac.uk/id/eprint/366836
ISSN: 1932-6203
PURE UUID: 09a997e2-ad16-46b0-bb2c-ea1622234854
Catalogue record
Date deposited: 11 Jul 2014 14:08
Last modified: 14 Mar 2024 17:17
Export record
Altmetrics
Contributors
Author:
Boyd C.P. Ghosh
Author:
Roger H.S. Carpenter
Author:
James B. Rowe
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics